- Janjigian, Y. Y., Kawazoe, A., Yanez, P. E., Luo, S. X., Lonardi, S., Kolesnik, O., . . . Tabernero, J., …Investigators, K.-. (2021). Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study. Journal of Clinical Oncology, 39(15). https://doi.org/10.1200/JCO.2021.39.15_suppl.4013 (Meeting abstract)
Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study
on 17 de gener de 2022
with No hi ha comentaris
Deixa un comentari